Research map: Intranasal gold nanoparticle-antigen induces mucosal and systemic immunity against β-coronaviruses

Back to the article

Papers in this map

  1. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor · Xing-Yi Ge · 2013 · 1901 citations · Cited by this paper
  2. From injection to inhalation: A STING‐activating mucosal adjuvant reprograms vaccination · Weijie Wang · 2026 · Cites this paper
  3. Engineering organoids toward implantable living therapeutics · 2026 · Related
  4. Tissue Processing and Hematoxylin and Eosin Staining · Ada T. Feldman · 2014 · 1101 citations · Cited by this paper
  5. Language model–driven discovery of antiviral peptides · 2026 · Related
  6. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function · Emma S. Winkler · 2020 · 1020 citations · Cited by this paper
  7. Dual strategies for durable antibodies against SARS-CoV-2: Immune trajectories and viral fitness constraints · 2025 · Related
  8. Manual Hematoxylin and Eosin Staining of Mouse Tissue Sections · Robert D. Cardiff · 2014 · 938 citations · Cited by this paper
  9. Polyfunctional varicella-zoster virus–reactive memory CD4+ T cells reside in human bone marrow · 2026 · Related
  10. Vaccine adjuvants: mechanisms and platforms · Tingmei Zhao · 2023 · 934 citations · Cited by this paper
  11. Longitudinal analysis identifies bystander-activated innate cytotoxic CD8+ T cells as predictors and therapeutic biomarkers for acute graft-versus-host disease · 2026 · Related
  12. Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo · Kenichi Niikura · 2013 · 638 citations · Cited by this paper
  13. Pseudomonas aeruginosa: From acute virulence to chronic persistence—mechanisms and therapeutic implications · 2026 · Related
  14. Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance · Mingze Xu · 2023 · 620 citations · Cited by this paper
  15. Uncovering the environmental dissemination of mobile tigecycline resistance · 2026 · Related
  16. Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses · Xiancai Ma · 2020 · 370 citations · Cited by this paper
  17. Genetic tool for specific tracking of mature neutrophils · 2026 · Related
  18. Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models · Neeltje van Doremalen · 2021 · 272 citations · Cited by this paper
  19. Golgi-derived COPI vesicles fuel the biogenesis of coronavirus replication organelles · 2026 · Related
  20. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response · Zezhong Liu · 2020 · 213 citations · Cited by this paper
  21. Peptide-based henipavirus entry inhibitors as pandemic countermeasures · 2026 · Related
  22. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases · Shen Wang · 2023 · 211 citations · Cited by this paper
  23. Dendritic Cells at the Oral Mucosal Interface · Christopher W. Cutler · 2006 · 180 citations · Cited by this paper
  24. Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs · Hanako Sekimukai · 2019 · 172 citations · Cited by this paper
  25. COVID‐19 Vaccines May Not Prevent Nasal SARS‐CoV‐2 Infection and Asymptomatic Transmission · Benjamin Saul Bleier · 2020 · 155 citations · Cited by this paper
  26. Tailoring inorganic nanoadjuvants towards next-generation vaccines · Xia Li · 2018 · 153 citations · Cited by this paper
  27. Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization · Tong Ye · 2023 · 148 citations · Cited by this paper
  28. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD · Yunjiao Zhou · 2021 · 145 citations · Cited by this paper
  29. The mucosal immune system of the respiratory tract · Shintaro Sato · 2012 · 132 citations · Cited by this paper
  30. Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases · Lev A. Dykman · 2020 · 132 citations · Cited by this paper
  31. Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines? · Mattia Tiboni · 2021 · 127 citations · Cited by this paper
  32. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs · Zezhong Liu · 2022 · 113 citations · Cited by this paper
  33. Cell-Penetrating Nanoparticles Activate the Inflammasome to Enhance Antibody Production by Targeting Microtubule-Associated Protein 1-Light Chain 3 for Degradation · Motao Zhu · 2020 · 104 citations · Cited by this paper
  34. Nanocarrier vaccines for SARS-CoV-2 · Jatin Machhi · 2021 · 101 citations · Cited by this paper
  35. Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies · Yingying Hou · 2023 · 88 citations · Cited by this paper
  36. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys · Cyril Le Nouën · 2022 · 59 citations · Cited by this paper
  37. Prevention of respiratory virus transmission by resident memory CD8+ T cells · Ida Elin Maria Uddback · 2023 · 56 citations · Cited by this paper
  38. Nasal vaccines for respiratory infections · Hiroshi Kiyono · 2025 · 53 citations · Cited by this paper
  39. Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery · Daniela Peneda Pacheco · 2019 · 51 citations · Cited by this paper

Source: OpenAlex (CC0)